209 related articles for article (PubMed ID: 2979807)
1. Cellular immune mechanisms in the pathogenesis of Crohn's disease.
James SP
In Vivo; 1988; 2(1):1-7. PubMed ID: 2979807
[TBL] [Abstract][Full Text] [Related]
2. Immune mechanisms in chronic inflammatory bowel disease.
Braegger CP; MacDonald TT
Ann Allergy; 1994 Feb; 72(2):135-41. PubMed ID: 8109803
[TBL] [Abstract][Full Text] [Related]
3. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
Rodrigues M; Zerbini MC; Barbieri D
Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869
[TBL] [Abstract][Full Text] [Related]
5. Intestinal and peripheral blood lymphocyte subpopulations in Crohn's disease.
Cagigas J; Echevarría S; Casafont F; Lozano JL; Rodríguez de Lope C; Pons Romero F
Allergol Immunopathol (Madr); 1987; 15(3):133-6. PubMed ID: 3499061
[TBL] [Abstract][Full Text] [Related]
6. [Activation of the major omentum-associated lymphoid tissue in Crohn disease].
Schreiber S; Gehrckens A; Raedler A
Zentralbl Chir; 1995; 120(2):135-44. PubMed ID: 7709665
[TBL] [Abstract][Full Text] [Related]
7. Modulation of intestinal immune system by dietary fat intake: relevance to Crohn's disease.
Miura S; Tsuzuki Y; Hokari R; Ishii H
J Gastroenterol Hepatol; 1998 Dec; 13(12):1183-90. PubMed ID: 9918423
[TBL] [Abstract][Full Text] [Related]
8. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.
Parronchi P; Romagnani P; Annunziato F; Sampognaro S; Becchio A; Giannarini L; Maggi E; Pupilli C; Tonelli F; Romagnani S
Am J Pathol; 1997 Mar; 150(3):823-32. PubMed ID: 9060820
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of Crohn's disease using Colibiogen. Cellular reactions of the immune system in patients with Crohn's disease].
Auer IO; Röder A; Mittelstaedt A
Fortschr Med; 1985 Dec; 103(46):1076-80. PubMed ID: 2935464
[No Abstract] [Full Text] [Related]
10. Expression of costimulatory molecules B7-1 and B7-2 in macrophages and granulomas of Crohn's disease: demonstration of cell-to-cell contact with T lymphocytes.
Hara J; Ohtani H; Matsumoto T; Nakamura S; Kitano A; Arakawa T; Nagura H; Kobayashi K
Lab Invest; 1997 Aug; 77(2):175-84. PubMed ID: 9274860
[TBL] [Abstract][Full Text] [Related]
11. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
12. The dyspeptic macrophage 30 years later: an update in the pathogenesis of Crohn's disease.
Caprilli R; Frieri G
Dig Liver Dis; 2009 Feb; 41(2):166-8. PubMed ID: 19026604
[TBL] [Abstract][Full Text] [Related]
13. Decreased lamina propria effector cell responsiveness to interleukin-10 in ileal Crohn's disease.
Colpaert S; Vanstraelen K; Liu Z; Penninckx F; Geboes K; Rutgeerts P; Ceuppens J
Clin Immunol; 2002 Jan; 102(1):68-76. PubMed ID: 11781069
[TBL] [Abstract][Full Text] [Related]
14. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
Brand S
Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis.
Sartor RB
Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):390-407. PubMed ID: 16819502
[TBL] [Abstract][Full Text] [Related]
16. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
[TBL] [Abstract][Full Text] [Related]
17. Activation of the CD2 pathway in lamina propria T cells up-regulates functionally active AP-1 binding to the IL-2 promoter, resulting in messenger RNA transcription and IL-2 secretion.
Gonsky R; Deem RL; Hughes CC; Targan SR
J Immunol; 1998 May; 160(10):4914-22. PubMed ID: 9590239
[TBL] [Abstract][Full Text] [Related]
18. [T-cell immunodeficiency and the status of the reparative processes in patients with Crohn's disease of the large intestine].
Kucher ND; Peshko AV; Radolitskiĭ SE; Zhel'man VA
Vrach Delo; 1990 Sep; (9):55-7. PubMed ID: 2284771
[TBL] [Abstract][Full Text] [Related]
19. Immunological studies on Crohn's disease. II. Lack of evidence for humoral and cellular dysfunctions.
Fujita K; Okabe N; Yao T
J Clin Lab Immunol; 1985 Mar; 16(3):155-61. PubMed ID: 3162025
[TBL] [Abstract][Full Text] [Related]
20. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
